What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Statistics
- Diabetes mellitus
His primary areas of investigation include Internal medicine, Type 2 diabetes, Endocrinology, Diabetes mellitus and Body mass index.
His Internal medicine study incorporates themes from Surgery and Cardiology.
The various areas that Stephen J. Sharp examines in his Type 2 diabetes study include Incidence, Randomized controlled trial, Mass screening and European Prospective Investigation into Cancer and Nutrition, Prospective cohort study.
His studies deal with areas such as Genome-wide association study and Allele as well as Endocrinology.
His Diabetes mellitus research incorporates themes from Heptadecanoic acid, Oncology, Environmental health, Gastroenterology and Genetic association.
Stephen J. Sharp has researched Body mass index in several fields, including Framingham Risk Score, Gerontology, Demography, Weight gain and Sedentary lifestyle.
His most cited work include:
- A genome-wide association search for type 2 diabetes genes in African Americans. (1727 citations)
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (1707 citations)
- Explaining heterogeneity in meta-analysis: a comparison of methods. (1308 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Type 2 diabetes, Diabetes mellitus, Prospective cohort study and Body mass index.
His research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with issues in Genome-wide association study.
His study looks at the intersection of Type 2 diabetes and topics like Incidence with Environmental health.
A large part of his Diabetes mellitus studies is devoted to Diabetes risk.
His Prospective cohort study research is multidisciplinary, incorporating perspectives in Epidemiology, Cohort, Hazard ratio, Confidence interval and Confounding.
His biological study spans a wide range of topics, including Physical therapy, Demography, Obesity and Gerontology.
He most often published in these fields:
- Internal medicine (34.46%)
- Type 2 diabetes (32.62%)
- Diabetes mellitus (23.69%)
What were the highlights of his more recent work (between 2017-2021)?
- Type 2 diabetes (32.62%)
- Internal medicine (34.46%)
- Diabetes mellitus (23.69%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Type 2 diabetes, Internal medicine, Diabetes mellitus, Prospective cohort study and Confidence interval.
The study incorporates disciplines such as Body mass index, European Prospective Investigation into Cancer and Nutrition, Cohort study, Meta-analysis and Hazard ratio in addition to Type 2 diabetes.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology, Oncology and Diabetes risk.
His work on Insulin resistance as part of his general Diabetes mellitus study is frequently connected to Mendelian randomization, thereby bridging the divide between different branches of science.
His Prospective cohort study study combines topics from a wide range of disciplines, such as Confounding, Demography, Epidemiology and Cohort.
His work carried out in the field of Demography brings together such families of science as Biobank and Incidence.
Between 2017 and 2021, his most popular works were:
- Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis (280 citations)
- Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. (144 citations)
- Human Gain-of-Function MC4R Variants Show Signaling Bias and Protect against Obesity (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Statistics
- Diabetes mellitus
His scientific interests lie mostly in Internal medicine, Type 2 diabetes, Prospective cohort study, Diabetes mellitus and Cohort study.
His Internal medicine study focuses mostly on Body mass index and Coronary artery disease.
Type 2 diabetes is a subfield of Endocrinology that Stephen J. Sharp studies.
The concepts of his Prospective cohort study study are interwoven with issues in Coronary heart disease, Smoking cessation, Epidemiology, Meta-analysis and Hazard ratio.
His Diabetes mellitus study combines topics in areas such as Odds ratio, Case-control study and Risk factor.
His Cohort study research integrates issues from Stroke, Mendelian Randomization Analysis, Cause of death and Cardiology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
